ABBOTT LABORATORIES

ABBOTT LABORATORIES

Abbott Laboratories (CIK 1800, ticker ABT) is a global healthcare leader providing life-changing medical devices, pharmaceuticals, diagnostics, and nutritional products across 160+ countries. The company generates significant revenue from its medical devices segment (45%), particularly in cardiovascular care, diabetes management through FreeStyle Libre, neuromodulation, and structural heart devices, alongside diagnostics (20%), nutritional products like Ensure and Pedialyte (22%), and established pharmaceuticals (13%). Abbott serves healthcare professionals, consumers, and institutional customers globally, with particular focus on underserved populations. Key material risks include declining COVID-19 diagnostic sales, regulatory scrutiny, intense competitive pricing pressures across all segments, foreign exchange volatility, and patent expirations affecting medical device portfolio. View Abbott's SEC filings on EarningsFeed to explore detailed financial performance and risk disclosures.